During #AIDS2024, Plus life in partnership with Gilead Sciences produced a series of interviews. Here, Karl Schmid sits with Dan Murphy, Senior Director, Government Affairs & Policy, and Mercy Shibemba, HIV Activist and Advocate, to discuss the Blueprint Report and where we are in terms of ending the HIV epidemic by 2030. Continue reading THE BLUEPRINT REPORT | Dan Murphy & Mercy Shibemba
During #AIDS2024, Plus Life in partnership with Gilead Sciences produced a series of interviews. Here, Karl Schmid sits with Moupali Das, Executive Director, Clinical Development, to discuss the greatest barriers to PrEP utilization. Continue reading BARRIERS TO PrEP? | Moupali Das
During #AIDS2024, Plus Life in partnership with Gilead Sciences produced a series of interviews. Here, Karl Schmid sits with Anja Wiese, Qualified Educator, AIDS-Hilfe Krefeld e.V. to discuss the HIVISION 100 report. Continue reading HIVISION 100 REPORT | Anja Wiese
During #AIDS2024, Plus Life in partnership with Gilead Sciences produced a series of interviews. Here, Karl Schmid sits with Derek Spencer, Executive Director, Government Affairs to discuss improving initial screenings and early testing for HIV and research. Continue reading INITIAL SCREENING & TESTING | Derek Spencer
During this crisis, we will be sharing a daily video from our Dr. Anu, on COVID-19 that will help you understand what’s going on, and how to best prepare yourself during this time of uncertainty. Here are some useful links to dig deeper on the topic of HIV: Newly Diagnosed with HIV https://www.cdc.gov/hiv/basics/livingwithhiv/newly-diagnosed.html Treatment as Prevention https://www.cdc.gov/hiv/risk/art/index.html U=U https://www.preventionaccess.org PrEP https://www.cdc.gov/hiv/basics/prep.html PEP – Treatment Immediately … Continue reading +SCIENCE: #CoronaVirus How Is Testing Being Done?
